INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

Infectious Diseases Now is a premier academic journal dedicated to the evolving field of infectious diseases, published by Elsevier France - Éditions Scientifiques Médicales Elsevier. With an ISSN of 2666-9927 and an E-ISSN of 2666-9919, this journal stands at the forefront of disseminating critical research and clinical insights from 2021 to 2024. The journal's commitment to open access means that groundbreaking studies are readily available to researchers, healthcare professionals, and students, fostering a collaborative approach to tackling global health challenges. As evidenced by its Q2 quartile ranking in the 2023 Scopus category of Infectious Diseases, and its impressive position within the top 25% of its field, Infectious Diseases Now serves as an essential resource for those involved in the study and management of infectious diseases. By publishing high-quality research, case studies, and reviews, the journal plays a pivotal role in advancing knowledge and improving patient care in this vital area of medicine.

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.

RISK ANALYSIS is a premier journal published by Wiley, focusing on the critical intersection of safety, risk, reliability, and quality within the fields of engineering and physiology. With a strong standing reflected in its Q1 category ranking in Safety, Risk, Reliability and Quality and Q2 in Physiology (medical), this journal is a vital resource for researchers, professionals, and students eager to stay informed on the latest methodologies, theories, and applications surrounding risk assessment and management. Since its inception in 1981, RISK ANALYSIS has been instrumental in shaping the discourse in its fields, garnering a robust reputation verified by its high rankings on Scopus, where it is positioned in the 85th percentile in Safety and the 77th percentile in Medicine. Though it does not currently offer Open Access options, the journal remains essential for those committed to advancing their understanding of risks associated with complex systems. For more insights, RISK ANALYSIS is available to readers throughout its converged years extending to 2024, solidifying its role as a foundational journal for impactful research.

Microbial Risk Analysis, published by Elsevier, is a pivotal academic journal specializing in the intersection of epidemiology, infectious diseases, and medical microbiology. With an ISSN of 2352-3522 and an E-ISSN of 2352-3530, this journal has been contributing to the field since its inception in 2016 and continues to invite groundbreaking research as it converges through 2024. With a respectable impact factor, Microbial Risk Analysis holds a Q3 designation in key categories, showcasing its credibility with ranks such as #48 in Epidemiology and #124 in Infectious Diseases according to Scopus. The journal serves as an essential platform for researchers, professionals, and students alike, aiming to enhance understanding of microbial risks and their public health implications. Although it operates under a subscription model, its contents remain accessible to a broad range of interdisciplinary scholars dedicated to advancing microbial research. For those at the forefront of epidemiological and infectious disease studies, Microbial Risk Analysis represents a crucial resource for disseminating knowledge and fostering collaboration.

Microbiology Australia is a prominent journal published by CSIRO PUBLISHING, focusing on the diverse and rapidly evolving field of microbiology. Since its transition to Open Access in 2021, it has broadened its accessibility, fostering greater dissemination of research findings among scholars and practitioners. The journal features a range of topics that are pivotal for understanding microbial systems in applied microbiology, medical microbiology, public health, and environmental applications. Despite its current categorization in the Q4 quartile across several categories, it remains an essential platform for emerging research and innovative methodologies. Researchers and professionals can benefit from the journal's commitment to enriching the global discourse on microbiological advancements. With its ISSN 1324-4272 and E-ISSN 2201-9189, Microbiology Australia caters to a wide audience in Australia and beyond, making significant strides in bridging the gap between research and practical applications in microbiology.

The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.